Canada Life’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-97,500
| Closed | -$1.9M | – | 2772 |
|
|
2018
Q1 | $1.9M | Sell |
97,500
-172
| -0.2% | -$3.38K | ﹤0.01% | 1182 |
|
|
2017
Q4 | $1.63M | Sell |
97,672
-3,200
| -3% | -$58.7K | ﹤0.01% | 1298 |
|
|
2017
Q3 | $2.13M | Sell |
100,872
-5,984
| -6% | -$114K | 0.01% | 1102 |
|
|
2017
Q2 | $1.72M | Buy |
106,856
+3,350
| +3% | +$49.5K | ﹤0.01% | 1261 |
|
|
2017
Q1 | $1.3M | Buy |
103,506
+7,298
| +8% | +$88.1K | ﹤0.01% | 1382 |
|
|
2016
Q4 | $1.28M | Sell |
96,208
-3,065
| -3% | -$52.4K | ﹤0.01% | 1376 |
|
|
2016
Q3 | $2.35M | Buy |
99,273
+8,484
| +9% | +$228K | 0.01% | 967 |
|
|
2016
Q2 | $2.62M | Buy |
90,789
+82,853
| +1,044% | +$2.7M | 0.01% | 881 |
|
|
2016
Q1 | $254K | Buy |
7,936
+1,810
| +30% | +$63.6K | ﹤0.01% | 1177 |
|
|
2015
Q4 | $262K | Hold |
6,126
| – | – | ﹤0.01% | 1149 |
|
|
2015
Q3 | $216K | Sell |
6,126
-36,800
| -86% | -$1.66M | ﹤0.01% | 1211 |
|
|
2015
Q2 | $1.97M | Sell |
42,926
-14,100
| -25% | -$669K | 0.01% | 804 |
|
|
2015
Q1 | $2.67M | Sell |
57,026
-8,900
| -13% | -$354K | 0.01% | 747 |
|
|
2014
Q4 | $2.09M | Buy |
65,926
+700
| +1% | +$20.5K | 0.01% | 771 |
|
|
2014
Q3 | $1.55M | Buy |
65,226
+61,800
| +1,804% | +$1.58M | 0.01% | 825 |
|
|
2014
Q2 | $102K | Hold |
3,426
| – | – | ﹤0.01% | 1571 |
|
|
2014
Q1 | $90K | Hold |
3,426
| – | – | ﹤0.01% | 1488 |
|
|
2013
Q4 | $87K | Buy |
+3,426
| New | +$76.4K | ﹤0.01% | 1469 |
|
Canada Life's IPXL Position: Q2 2018 in Review
Canada Life sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 97,500 shares — an estimated $1.9M sold.
Canada Life first reported a position in IPXL in Q4 2013 and held it in 18 quarters. The position peaked at $2.67M in Q1 2015. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.
- Canada Life reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
- Canada Life sold 97,500 Impax Laboratories, Inc. shares in Q2 2018, an estimated $1.9M.
- Canada Life first reported a position in Impax Laboratories, Inc. in Q4 2013 and held it in 18 quarters.
- Canada Life's Impax Laboratories, Inc. position peaked at $2.67M in Q1 2015.
- 1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.
Based on Canada Life's 13F filing for Q2 2018, filed 10 Aug 2018.